Multiple myeloma is a hard cancer to cure. But there may be some good news on that front.

According to new predictions, 2016 will be a good year for leukemia.

Doctors may now have another tool in their arsenal for the treatment of chronic lymphocytic leukemia (CLL).

The American College of Chest Physicians (CHEST) issued some new guidelines for the treatment of venous thromboembolism (VTE).

Cancer patients have enough to worry about — they shouldn't have to worry about the health effects of medications taken before cancer surgery. And new evidence suggests they may not have to.

Antiplatelet medications, while highly effective, can put surgical patients at risk of serious bleeding. But a new, safer drug may be on the horizon.

Patients may now have an alternative to chemotherapy as their first line of defense against chronic lymphocytic leukemia (CLL).

Patients with von Willebrand disease (VWD) lack a protein that's essential for healthy blood clotting. But a newly approved medication could help with that.

For kids with acute lymphoblastic leukemia (ALL), bacterial infections can cause dangerous complications. But a new treatment option may be able to help.

Before November, there were seven FDA-approved medications to treat multiple myeloma. Now that November is over, there are 10.